This research represents a novel exploration into the MRGs of SLE, identifying FAM210B, MSRB2, LYRM7, IFI27, and SCO2 as significant candidates for classifying and therapeutic targeting. This evidence concerns the gene MIMS2 and systemic lupus erythematosus.